The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases

被引:782
|
作者
Chowdhury, Rasheduzzaman [1 ]
Yeoh, Kar Kheng [1 ]
Tian, Ya-Min [2 ]
Hillringhaus, Lars [1 ]
Bagg, Eleanor A. [1 ]
Rose, Nathan R. [1 ]
Leung, Ivanhoe K. H. [1 ]
Li, Xuan S. [3 ]
Woon, Esther C. Y. [1 ]
Yang, Ming [1 ]
McDonough, Michael A. [1 ]
King, Oliver N. [1 ]
Clifton, Ian J. [1 ]
Klose, Robert J. [3 ]
Claridge, Timothy D. W. [1 ]
Ratcliffe, Peter J. [2 ]
Schofield, Christopher J. [1 ]
Kawamura, Akane [1 ]
机构
[1] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England
[2] Univ Oxford, Dept Clin Med, Oxford OX3 7BN, England
[3] Univ Oxford, Dept Biochem, Epigenet Regulat Chromatin Funct Grp, Oxford OX1 3QU, England
基金
英国生物技术与生命科学研究理事会; 英国惠康基金;
关键词
isocitrate dehydrogenase; 2-hydroxyglutarate; 2-oxoglutarate; oxygenases; hypoxia-inducible factor; HYPOXIA-INDUCIBLE FACTOR; ISOCITRATE DEHYDROGENASE 1; PROLYL HYDROXYLASE; STRUCTURAL BASIS; MUTATIONS; CANCER; TRANSCRIPTION; SPECIFICITY; HIF-1-ALPHA; METABOLISM;
D O I
10.1038/embor.2011.43
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in isocitrate dehydrogenases (IDHs) have a gain-of- function effect leading to R(-)-2-hydroxyglutarate (R-2HG) accumulation. By using biochemical, structural and cellular assays, we show that either or both R-and S-2HG inhibit 2-oxoglutarate (2OG)-dependent oxygenases with varying potencies. Half-maximal inhibitory concentration (IC(50)) values for the R-form of 2HG varied from approximately 25 mu M for the histone N(epsilon)-lysine demethylase JMJD2A to more than 5mM for the hypoxia-inducible factor (HIF) prolyl hydroxylase. The results indicate that candidate oncogenic pathways in IDH-associated malignancy should include those that are regulated by other 2OG oxygenases than HIF hydroxylases, in particular those involving the regulation of histone methylation.
引用
收藏
页码:463 / 469
页数:7
相关论文
共 50 条
  • [21] Focused Screening Identifies Different Sensitivities of Human TET Oxygenases to the Oncometabolite 2-Hydroxyglutarate
    Belle, Roman
    Sarac, Hilal
    Salah, Eidarus
    Bhushan, Bhaskar
    Szykowska, Aleksandra
    Roper, Grace
    Tumber, Anthony
    Kriaucionis, Skirmantas
    Burgess-Brown, Nicola
    Schofield, Christopher J.
    Brown, Tom
    Kawamura, Akane
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (06) : 4525 - 4540
  • [22] The effect of oncometabolite 2-hydroxyglutarate on the biological behavior of differentiated melanocytes and uveal melanoma cells
    Weidmann, Cindy
    Quirke, Colm F.
    Yao, Christine
    Lowry, Carolyne Mary
    Pomerleau, Jade
    Wagner, J. Richard
    Landreville, Solange
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [23] The oncometabolite 2-hydroxyglutarate produced by mutant IDH1 sensitizes cells to ferroptosis
    Wang, Tian-Xiang
    Liang, Jun-Yun
    Zhang, Cheng
    Xiong, Yue
    Guan, Kun-Liang
    Yuan, Hai-Xin
    CELL DEATH & DISEASE, 2019, 10 (10)
  • [24] Oncometabolite D-2-hydroxyglutarate inhibits complement activation
    Lin, Feng
    Zhang, Lingjun
    Sorensen, Mia D.
    Kristensen, Bjarne W.
    Reifenberger, Guido
    McIntyre, Thomas M.
    MOLECULAR IMMUNOLOGY, 2018, 102 : 183 - 183
  • [25] Evaluation of the tissue distribution of oncometabolite 2-hydroxyglutarate in gliomas using mass spectrometry imaging
    Hayashi, Mitsuhiro
    Ohno, Makoto
    Ichimura, Koichi
    Yoshida, Akihiko
    Narita, Yoshitaka
    Hamada, Akinobu
    CANCER SCIENCE, 2018, 109 : 821 - 821
  • [26] Histone lysine demethylases and cancer
    Agger, Karl
    Cloos, Paul A. C.
    Christensen, Jesper
    Helin, Kristian
    APMIS, 2008, 116 (05) : 423 - 423
  • [27] 2-HYDROXYGLUTARATE IN CRUSTACEANS
    HUGGINS, AK
    BOULTON, AP
    BIOCHEMICAL JOURNAL, 1971, 125 (04) : 1141 - +
  • [28] The oncometabolite (R)-2-hydroxyglutarate modulates stress-induced caspase activity in glioma cells
    Gilbert, Misty
    Liu, Yinxing
    Morris, Andrew
    Sunkara, Manjula
    Kyprinaou, Natasha
    Horbinski, Craig
    CANCER RESEARCH, 2012, 72
  • [29] Oncometabolite D-2-Hydroxyglutarate enhances gene silencing through inhibition of specific H3K36 histone demethylases
    Janke, Ryan
    Iavarone, Anthony T.
    Rine, Jasper
    ELIFE, 2017, 6
  • [30] Malignant Glioma Genotyping by CSF 2-Hydroxyglutarate Oncometabolite and IDH1 Mutation Analysis
    Balaj, Leonora
    Lok, Edwin
    Swanson, Kenneth D.
    Asara, John M.
    Chen, Clark C.
    Hochberg, Fred
    Breakefield, Xandra O.
    Wong, Eric T.
    ANNALS OF NEUROLOGY, 2012, 72 : S123 - S123